Covid19
Showing NaN - NaN of 19
SARS-CoV Infection, Covid19 Trial in Mexico, Puerto Rico, United States (SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination
Active, not recruiting
- SARS-CoV Infection
- Covid19
- SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
- +5 more
-
Birmingham, Alabama
- +155 more
Dec 16, 2022
Covid19 Trial in United States (Sotrovimab)
No longer available
- Covid19
- Sotrovimab
-
Palo Alto, California
- +3 more
Nov 4, 2022
Covid19 Trial in United States (sotrovimab)
Recruiting
- Covid19
- sotrovimab
-
Riverside, California
- +9 more
Nov 2, 2022
COVID-19 Respiratory Outcomes Registry
Active, not recruiting
- Covid19
- Questionnaires and Patient Reported Outcomes (PROs)
- +10 more
-
Saint Louis, Missouri
- +3 more
Oct 11, 2022
Covid19 Trial in United States (Screening testing strategy, No screening testing strategy)
Active, not recruiting
- Covid19
- Screening testing strategy
- No screening testing strategy
-
Hazelwood, Missouri
- +4 more
Aug 22, 2022
Covid19 Trial in Saint Louis (Text message)
Completed
- Covid19
- Text message
-
Saint Louis, MissouriAscension
Jul 18, 2022
Covid19 Trial in United States (Apixaban 2.5 MG, Placebo)
Active, not recruiting
- Covid19
- Apixaban 2.5 MG
- Placebo
-
Phoenix, Arizona
- +120 more
Jul 1, 2022
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Recruiting
- Covid19
- theraputic heparin
- +4 more
-
Birmingham, Alabama
- +101 more
Jun 28, 2022
Covid19, SARS-CoV-2 Infection Trial in Iowa City, Saint Louis (GC4419, Placebo)
Covid19, Anosmia, Olfactory Disorder Trial in Saint Louis (Theophylline Powder)
Completed
- Covid19
- +7 more
- Theophylline Powder
-
Saint Louis, MissouriWashington University School of Medicine in Saint Louis
Feb 1, 2022
Feasibility Study of Hematology Parameters in COVID-19 Disease
Completed
- Covid19
- +3 more
- CBC-Diff Monocyte Volume Width Distribution
-
Saint Louis, MissouriWashington University
Dec 5, 2021
Biomarkers of Trained Immunity Following MMR Vaccination
Completed
- Covid19
- Heterologous stimuli
- Neutralization assay
-
Saint Louis, MissouriWashington University School of Medicine
Nov 24, 2021
Covid19, Intellectual Disability, Developmental Disability Trial in Baltimore, Kansas City, Saint Louis (General Communication
Recruiting
- Covid19
- +3 more
- General Communication Message
- +3 more
-
Baltimore, Maryland
- +2 more
Jul 19, 2021
Anosmia, Covid19, Ageusia Trial in Saint Louis (Smell Training)
Active, not recruiting
- Anosmia
- +6 more
- Smell Training
-
Saint Louis, MissouriWashington University School of Medicine in Saint Louis
Apr 2, 2021